Tests an AI chatbot to help women join cervical cancer screening
Tests an AI chatbot decision aid for women aged 30 to 65 offered HPV self-sampling.
Plain-language title generated from the registry record
Registry title: Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
Key facts
- Where
- Carcassone, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 65 years old?
Source: NCT05286034, who can take part
Where in France
- Centre Régional de Coordination des Dépistages des Cancers-Centre d'OccitanieCarcassone, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- International Agency for Research on Cancer
- Trial code
- NCT05286034
- Record updated
- 27 March 2026
- Original description
This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.Read full original descriptionShow less
Artificial Intelligence-assisted Decision-making to Improve Women's Participation to Cervical Cancer Screening in Occitanie Region-France
This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.
Inclusion: aged 30-65; did not perform a pap smear in the last 4 years; are living in deprived clusters in the Occitanie region; did not answer to a first "invitation" letter to perform a clinician-collected HPV testing.
Exclusion: outside the target age group; had a Pap smear in the past 3 years; had hysterectomy including cervix; are pregnant; already scheduled a screening appointment or had just attended a HPV screening; had a cervical abnormality that was under exploration and/or treatment; participated to the study pilot.